Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) FCF Margin (2016 - 2026)

Rockwell Medical filings provide 16 years of FCF Margin readings, the most recent being 12.29% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 1039.0% to 12.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.73%, a 488.0% decrease, with the full-year FY2025 number at 1.73%, down 488.0% from a year prior.
  • FCF Margin hit 12.29% in Q4 2025 for Rockwell Medical, up from 9.96% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 14.42% in Q3 2024 to a low of 81.0% in Q1 2021.
  • Median FCF Margin over the past 5 years was 10.59% (2023), compared with a mean of 18.17%.
  • Biggest five-year swings in FCF Margin: crashed -3849bps in 2021 and later soared 5758bps in 2022.
  • Rockwell Medical's FCF Margin stood at 59.61% in 2021, then soared by 97bps to 2.03% in 2022, then skyrocketed by 81bps to 0.39% in 2023, then soared by 590bps to 1.91% in 2024, then skyrocketed by 545bps to 12.29% in 2025.
  • The last three reported values for FCF Margin were 12.29% (Q4 2025), 9.96% (Q3 2025), and 10.45% (Q2 2025) per Business Quant data.